MGX — TIDES USA 2025 - Oral Presentation

May 22, 2025, 10:30:00 PM UTC

conference talk

Summary

Metagenomi will present an oral session on AI-guided discovery of CRISPR systems for therapeutic genome editing at TIDES USA 2025.

Location: Manchester Grand Hyatt San Diego

Company

METAGENOMI INC (MGX)

NASDAQ — Healthcare: Manufacturing, Biotechnology: Biological Products (No Disgnostic Substances)

www.metagenomi.co

Similar Events

May 19, 2025, 4:00:00 AM UTC

TIDES USA 2025 Conference

Editas Medicine will present preclinical data and participate in panel discussions at the TIDES USA 2025 Conference from May 19-22, focusing on oligonucleotide and peptide therapeutics. This conference is significant for the biotech sector, showcasing advancements in drug development and delivery technologies.

conference talk
May 13, 2025, 11:00:00 PM UTC

ASGCT 2025 Annual Meeting - Poster Presentation

Metagenomi will present three posters at the ASGCT 2025 Annual Meeting, showcasing advancements in genome editing technologies.

conference talk
May 14, 2025, 7:30:00 PM UTC

Oral Presentation at ASGCT

Editas Medicine will present preclinical data on in vivo gene editing at the ASGCT Annual Meeting, focusing on innovative delivery methods and therapeutic strategies.

conference talk
May 21, 2025, 4:30:00 PM UTC

Codexis Oral Presentation: Oligonucleotide CMC at TIDES USA

Codexis, Inc. will deliver an oral presentation on sustainable and scalable enzymatic siRNA manufacturing at the TIDES USA conference in San Diego on May 21, 2025. Alison Moore, PhD, Chief Technical Officer, will discuss advances in oligonucleotide chemistry, manufacturing, and controls (CMC) for siRNA therapeutics. The presentation highlights Codexis’s enzymatic solutions for efficient RNA drug production, a key area for contract development and manufacturing organizations (CDMOs) and biopharma partners. TIDES USA is a leading industry event focused on oligonucleotide and peptide therapeutics.

conference talk